drugset / Trial / NCT06828120
A Randomized, Safety and Efficacy Study of Taneasy 600mg Granules and Fluimucil 600mg Granules in COPD Subjects
Phase 4
Completed
45 enrolled
Bun Yao Biotechnology Co., Ltd
Clinny biotech limited · collabTaipei Veterans General Hospital, Taiwan · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the safety and efficacy of Taneasy 600mg granules and Fluimucil 600mg granules administered twice daily for 14 days in treatment of COPD Disease.
Timeline
- Start
- 2025-02-20
- Primary completion
- 2025-09-03
- Completion
- 2025-09-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | N-acetylcysteine | Small molecule | 600 mg | — |
| Subject | Taneasy | Unknown | 600 mg | — |